Sorry, you need to enable JavaScript to visit this website.

COVID-19

Alternative labels
Coronavirus disease 2019
Novel coronavirus pneumonia
2019-nCoV acute respiratory disease
Subject Hierarchy
Broader terms
Infectious diseases
Current term
COVID-19
Permalinks
APO URI

ADVERTISEMENT

Report

Who wants to get boosted? COVID-19 vaccine uptake in Australia in January 2022


In October 2021, the Australian government commenced the rollout of COVID-19 booster vaccines, making them available to adults who had previously received two primary doses. Despite the wide availability of booster vaccines to eligible adults, take-up has remained relatively low. This paper highlights that in order to increase the level of the Australian population vaccinated...
Report

Future-proofing safety


The Centre for Family Research and Evaluation has recently commenced 'Future-proofing Safety', a major research project examining how family violence in Victoria has changed since the COVID-19 pandemic began. This first interactive report includes three organisational case studies, each exploring family violence service data before and during COVID-19.
Report

Vaccine related fraud and security risks: final report


This inquiry was established to to identify and address any vulnerabilities that had or potentially could emerge, in relation to vaccine and vaccine related fraud and security, and provide the Australian public with confidence in the integrity of the COVID-19 vaccination program.
Report

Tracking wellbeing outcomes during the COVID-19 pandemic (January 2022): riding the Omicron wave


This paper provides a summary of COVID-19 and wellbeing data from the January 2022 ANUpoll, the tenth poll in the ANU Centre for Social Research and Methods COVID-19 Impact Monitoring Survey program.
Report

Money calls the shots: pharma's response to the COVID-19 vaccines crisis


This report argues that, despite receiving billions in public funding, a number of pharmaceutical companies are continuing to put their own business interests before their human rights responsibilities by creating barriers to fair access to their COVID-19 vaccines through their decisions not to share intellectual property and technology.